Abstract and Summary.-Evidence has been presented for the existence of an acidic protein(s) or protein portion of a more complex molecule which has a high affinity for binding noncovalently a biologically active metabolite of vitamin D. This molecule could be solubilized from the residual chromatin via treatment with either 0.3 M KCl or high pH and has been purified 167-fold over the crude mucosa homogenate. Characterization of the still crude receptor fraction showed that it contains significant amounts of RNA and that it may exist in multiple forms, i.e., a 50,000-70,000 and a >200,000 molecular weight species. The binding capacity of the receptor fraction for the metabolite is saturated after administration of a physiological dose of the parent vitamin D.
The presence of vitamin D is essential to the development and continued operation of a mechanism for the absorption of calcium by the intestinal mucosa.'-3 It has been proposed that vitamin D may generate this characteristic physiological response via its ability to activate or stimulate the biochemical expression of genetic information to induce the synthesis of enzymes or the alteration of membrane structure necessary for calcium absorption.1' 2. [4] [5] [6] This hypothesis was based primarily on the observation that actinomycin D treatment completely blocked the intestinal response to vitamin D.2' 4 6 Subsequently, it was found that vitamin D could stimulate the incorporation of 3H-uridine or 3H-orotic acid into intestinal mucosa RNA.7 8 Specific information as to how the vitamin might be initiating this proposed series of biochemical events requires a knowledge of the subcellular location of physiological amountst of radioactive vitamin D3 and its metabolites. We have previously reported that, after a physiological dose of 3H-vitamin D3, the radioactivity isolated from the target intestinal mucosa of rachitic chicks was located primarily in the nuclear fraction9 and, more specifically, in the nuclear chromatin fraction(s). Organic solvent extraction and chromatography of the radioactivity present in the entire intestinal mucosa indicated the presence of at least three metabolites of vitamin D. However, 85-90 per cent of only one of these metabolites was associated exclusively with the chromatin fraction.5 This metabolite, which is more polar than vitamin D, was found to have biological activity equivalent to that of the parent vitamin D.
In this communication, we wish to report the existence and isolation of a macromolecular receptor for the biologically active polar metabolite of vitamin D from the chromatin fraction of the intestinal mucosa.
Materials and Methods. hjem homogenizer equipped with a Teflon pestle. This solution was then centrifuged at 27,000 X g for 1 hr to sediment the residual chromatin. The resulting supernatant fluid was then dialyzed against saturated (NH4)2SO4 at 0C for 5 hr to precipitate the receptor fraction. The precipitate which could be harvested via centrifugation at 27,000 X g for 1 hr was termed the crude receptor fraction. Radioactivity measurements: All samples which were to be assayed for radioactivity content were extracted according to a slight modification of the procedure of Bligh and Dyer13 as previously reported.5 The resulting chloroform layer was evaporated to dryness with air in a liquid scintillation vial, and 10 ml of a counting solution consisting of 5 gm of phenylbiphenyl oxadiazole-1,3,4 (PBD) per liter of toluene was added. The sample was counted to 2% error in a Beckman CPM-200 liquid scintillation counter. The number of dpm of tritium and carbon-14 was determined by the use of subsequently added internal standards of 'H-toluene or '4C-benzene. The usual efficiency for carbon-14 was 65-70%, and for tritium it was 35-45%.
Chemical assays: The diphenylamine method of Dische'4 was utilized for DNA analysis, and the orcinol procedure' was employed for RNA analysis. In samples containing both RNA and DNA, the RNA data were corrected for the amount of DNA present. Protein was determined by the method of Lowry."6
Results.-That the active metabolite of vitamin D is bound to a macromolecular receptor in the intestinal chromatin fraction is shown in Figure 1 (pelle FRACTION NUMBER(lmI) (skin) radioactivity associated with the +D chromatin was present only in the protein skin.
The results of Figure 1 prompted an examination of the chemical conditions or environment that might be utilized to dissociate the receptor + metabolite from the chromatin. A summary of the results obtained is shown in Table 1 . In all these studies the end poinit followed was the removal from the chromatin of the radioactive metabolite. Acid conditions were not capable of significantly removing radioactivity, which suggests that the metabolite is not associated with a histone fraction. High pH conditions, on the other hand, were found to remove about 70 per cent of the chromatin-bound radioactivity. When the pH 10 or pH 12 extract was treated with trichloroacetic acid (TCA), the 14C-metabolite was precipitated, an indication that it had been extracted while bound to a TCAprecipitable macromolecule. Successive treatment of the chromatin with 1 per cent Triton X-100 in 0.01 M Tris-HCl, pH 7.5, was incapable of removing vitamin D3. After treatment of the chromatin with the prescribed agent, it is reharvested by centrifuration and assayed for 14C-radioactivity.
significant amounts of the '4C-metabolite. This suggests that the "4C-metabolite is tightly and specifically associated with some entity of the chromatin fraction, since treatment of subcellular fractions with this nonionic detergent has been shown to effect removal of nonspecifically bound lipids.5
By far the most gentle and effective means of solubilizing the metabolite while bound to a macromolecule was the treatment of the chromatin with moderate concentrations of KC1. The stepwise removal of proteins from the chromatin with increasing concentrations of KCI is shown in Figure 2 
peak was not determined experimentally; the estimated value of p = 1.28 gm/ml was obtained from Maurer and Chalkley.17
As shown in Figure 3 , the receptor and bound metabolite band together in a symmetrical peak at a density of 1.28 after centrifugation to equilibrium in 2.0 M CsCl. These results are somewhat analogous to that obtained by Maurer and Chalkley for a chromatin-bound receptor for estrogen.'7
Further indications of the complex composition of the receptor fraction for the metabolite of vitamin D3 are depicted in Figure 4 . Chromatography of the crude receptor fraction + '4C-metabolite on a 1.5 X 100-cm Sephadex G-200 column results in the appearance of two broad peaks of UV absorbance. The first emerges with the exclusion volume, while the second peak emerges at a point equivalent to a molecular weight of 50,000-70,000.18 Both peaks contain the "4C-metabolite, and the possibility of some sort of multimer is suggested by the high molecular weight of the first peak. We have obtained essentially analogous results after sucrose gradient centrifugation. As shown in Figure 4 , incubation of the crude receptor fraction with RNase and DNase followed by Sephadex G-200 chromatography reduces the high-molecular-weight species and correspondingly increases the amount of the second peak. This perhaps indicates that nucleic acids may be involved in the formation of the multimer. In contrast, incubation of the crude receptor fraction with pronase for 15 hours at 200C, followed by Sephadex G-200 chromatography, destroys the binding of the 14C-metabolite to macromolecules, for the '4C-metabolite now emerges from the column in the region of small molecules. Since the receptor molecule is destroyed by pronase, but not RNase or DNase, it is inferred that the metabolite is bound to a protein or protein portion of a more complex molecule. As shown in Figure 5 , the receptor has only a finite capacity to bind the vitamin D3 metabolite. The binding capacity of the chromatin receptor is saturated after a dose of 25-30 IU (1.62-1.95 nmoles), and no increase is seen as the dose rises to 1000 IU (65 nmoles). This criterion of saturability is consistent with the concept that a specific site or molecule exists within the crude receptor fraction for the metabolite of vitamin D.
Also shown in Figure 5 are the results of administering to rachitic chicks increasing amounts of two vitamin D3 analogs,t G-3H-vitamin D2 and G-3H-dihydrotachysterol2. Significantly less radioactivity from both these compounds is bound to the crude receptor fraction. Although a dose of 25-30 IU of G-3H-vitamin D2 saturates the receptor, it is pertinent to note that the plateau value of 0.02 IU (1.3 pmoles) per crude receptor from one chick is only 40 per cent of the plateau value observed for vitamin D3. In the chick, vitamin D2 has only one tenth the biological activity of D3.
Discussion.-This paper provides evidence for the existence at the genome of a target tissue for vitamin D, the intestinal mucosa, of a macromolecular receptor for a biologically active metabolite of the vitamin. A previous report from this laboratory has documented that [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] The differing saturation plateaus in the receptor fraction (Fig. 5 ) resulting after separate administration of radioactive vitamin D2, D3, and dihydrotachysterol2 may provide a fundamental insight into the known differences in biological activity of these compounds.'0 t t It is possible that the lower plateau value for vitamin D2 is a reflection of less efficient binding of the analogous vitamin D2-polar metabolite to the receptor or, in turn, a less efficient association of this combination with the genome. Similarly a larger dose of G-3H-dihydrotachysterol2 is required to approach the saturation of the receptor. On the other hand, it is possible that compared to vitamin D3, the active polar metabolites are less efficiently produced from the native D2 vitamins. A detailed answer to this question must await the completion of a comparative study of all the vitamin D analogs and characterization of their metabolites.
